Edison, NJ, United States of America

Maria L Garcia

USPTO Granted Patents = 14 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • Rahway, NJ (US) (1998)
  • Edison, NJ (US) (1990 - 2008)

Company Filing History:


Years Active: 1990-2008

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Maria L Garcia: Innovator in Ophthalmic Treatments

Introduction

Maria L Garcia is a prominent inventor based in Edison, NJ, with a remarkable portfolio of 14 patents. Her work primarily focuses on ophthalmic compositions aimed at treating ocular hypertension and related conditions. Garcia's innovative contributions have significantly advanced the field of eye care, particularly in the treatment of glaucoma.

Latest Patents

Among her latest patents, Garcia has developed formulations that utilize potent potassium channel blockers for the treatment of glaucoma. One notable invention is an ophthalmic composition designed to address elevated intraocular pressure in patients. This invention not only targets the treatment of glaucoma but also aims to provide a neuroprotective effect to the eyes of mammalian species, especially humans. Another significant patent involves maxi-k channel blockers, which similarly focus on treating conditions related to elevated intraocular pressure while offering neuroprotective benefits.

Career Highlights

Throughout her career, Maria L Garcia has worked with esteemed organizations such as Merck & Company, Inc. and Evotec OAI. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research and development in ophthalmology.

Collaborations

Garcia has collaborated with notable colleagues, including Gregory J Kaczorowski and Owen B McManus. These partnerships have fostered a dynamic exchange of ideas and expertise, further enhancing her innovative work in the field.

Conclusion

Maria L Garcia's contributions to ophthalmic treatments through her patents and collaborations highlight her significant impact on eye care. Her dedication to innovation continues to pave the way for advancements in the treatment of ocular conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…